(R)-SLV 319 化学特性,用途語,生産方法
説明
Central cannabinoid (CB
1) receptor antagonists may have potential in the treatment of a number of diseases such as neuroinflammatory disorders, cognitive disorders, septic shock, obesity, psychosis, addiction, and gastrointestinal disorders. (R)-
SLV 319 is the inactive enantiomer of SLV 319 with 100-
fold less affinity for the CB
1 receptor. SLV 319 is a potent and selective CB
1 receptor antagonist with K
i values of 7.8 and 7,943 nM for CB
1 and peripheral cannabinoid (CB
2) receptors, respectively. SLV 319 is less lipophilic (log P = 5.1) and therefore more water soluble than other known CB
1 receptor ligands.
(R)-SLV 319 上流と下流の製品情報
原材料
準備製品